Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Biomedical Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9434 Online ISSN: 2049-9442
Journal Cover
March-2015 Volume 3 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2015 Volume 3 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Comparison of the post-mortem interval on the effect of vascular responses to the activation of ionotropic and metabotropic receptors

  • Authors:
    • Elżbieta Bloch‑Bogusławska
    • Elżbieta Grześk
    • Grzegorz Grześk
  • View Affiliations / Copyright

    Affiliations: Department of Forensic Medicine, Collegium Medicum Nicolaus Copernicus University, Bydgoszcz 85‑094, Poland, Department of Pharmacology and Therapeutics, Collegium Medicum Nicolaus Copernicus University, Bydgoszcz 85‑094, Poland
  • Pages: 230-234
    |
    Published online on: December 3, 2014
       https://doi.org/10.3892/br.2014.396
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The contractibility of blood vessels depends on their normal structure and the availability of calcium ions; it changes under the influence of numerous contracting and relaxing factors, which control the activities of various pathways of intracellular and intercellular signaling. The main aim of the study was to investigate, by means of perfusion pressure in rat tail arteries, the role of Ca2+ in vascular response to α‑1 adrenoceptor activation by phenylephrine (PHE) and Bay K8644 agonist of the L‑type calcium channel and caffeine before and after a post‑mortem interval (PMI) of 2, 4, 6 and 8 h. A phasic increase of perfusion pressure in rat tail arteries, as induced by PHE or caffeine, in Ca2+‑free solutions was used as an indicator of intracellular Ca2+ release through the inositol 1,4,5‑triphosphate and ryanodine receptor pathways, respectively. In Ca2+‑free‑ethylene glycol tetraacetic acid (EGTA)‑poly(sodium styrenesulfonate) (PSS) and in Ca2+‑EGTA‑PSS, the PHE induced elevation of perfusion pressure significantly decreased. Vascular responses to caffeine (20 mmol/l) in Ca2+‑free‑EGTA‑PSS, with an increase of PMI from 2‑8 h, did not change significantly. A similar effect was observed with vascular responses to KCl 40 mmol/l in Ca2+‑EGTA‑PSS. To confirm whether the inhibitory effect of 2, 4, 6 and 8 h PMI was mediated through the formation of NO, nitro‑L‑arginine (L‑NNA), a potent NO synthase inhibitor, was used. Exposure to L‑NNA (10‑5 M) blocked the inhibition induced by an increase of PMI. The blocked effects of L‑NNA were reversed by L‑arginine (10‑4 M). In conclusion, these patterns of change in artery responses provide insight into the post‑mortem change in the receptor‑mediated signaling components in epithelial and smooth muscle cells, and support the further study of post‑mortem vascular responses triggered by G protein‑coupled receptors (metabotropic) and channel‑linked receptors (ionotropic) as potential markers for estimating short and long‑term PMIs, respectively.

Introduction

Blood vessel contractibility depends on their normal structure and the availability of calcium ions. The contractibility changes under the influence of numerous contracting (such as angiotensin II and endothelin-1) and relaxing [including nitric oxide (NO) and prostacyclin] factors, which control the activities of various pathways of intracellular and intercellular signaling. Perfusion pressure in rat tail arteries were investigated in the present study, to investigate the role of Ca2+ in vascular response to activation α-1 adrenoceptor by phenylephrine (PHE) and Bay K8644 agonist of the L-type calcium channel and caffeine before and after a post-mortem interval (PMI) of 2, 4, 6 and 8 h. An elevated intracellular concentration of free calcium ions is considered a primary toxic mechanism in tissue damage (1–5). Mobilization tissues and an influx of calcium has long been considered as a major mechanism of ischemic cell death induced by different means, including ischemia (7–10). The increased concentration of cytoplasmic free-Ca2+ following hypoxia is derived from an influx and release from intracellular storage, such as endoplasmic reticulum (ER) and mitochondria.

Previous evidence indicated that mobilization of the intracellular calcium is in itself sufficient to activate apoptosis (10). This is supported by our finding that inhibition of nitric oxide synthase (NOS) elevated resistance to treatment with CaCl2, which mimics hypoxic stress and leads to the influx of calcium (5, 6). Treatment with 300 µM CaCl2 is commonly used to mimic hypoxic insults in vivo and in vitro.

The decrease in calcium influx (Ca2+)i can be observed through different mechanisms, including inhibition of Ca2+ entry across the plasma membrane and inhibition of intracellular Ca2+ release. NO has an inhibitory effect on Ca2+ entry through the voltage-gated calcium channel in vascular smooth muscle. Inconsistent results have been reported regarding how NO affects intracellular Ca2+ release. The vascular relaxation by NO is caused partly by the reduction of intracellular Ca2+ release. NO has been found to not influence arg8-vasopressin-induced intracellular Ca2+ release (5).

The present study was designed to investigate whether NO interfered with the Ca2+ influx from the extracellular space and release from intracellular storage. L-NNA was used to analyze the role of NO in the modification of post mortem vascular reactivity. More over experiments on normal arteries and endothelium denudated arteries were performed to got clear results.

A phasic increase of perfusion pressure in rat tail arteries induced by PHE or caffeine in Ca2+-free solution was used as an indicator of intracellular Ca2+ release through the inositol 1,4,5-triphosphate (IP3) and ryanodine receptor pathways, respectively. In Ca2+-free-ethylene glycol tetraacetic acid (EGTA)-poly(sodium styrenesulfonate) (PSS) in the presence Bay K8644 and KCl did not increase of perfusion pressure (11). Bay K and KCl induced an increase of perfusion pressure that was observed only in Ca2+-PSS. The increases of perfusion pressure induced by Bay K and KCl were used as an indicator of Ca2+-influx from extracellular space to cytoplasm through the Ca2+-channel in the cellular membrane.

The influence of PMI on the PHE and caffeine treatment evoked a phasic increase of perfusion pressure in Ca2+-free solution in endothelium intact and endothelium-denuded rat tail arteries were studied.

Materials and methods

Perfusion pressure study

A male Wistar rat (250–300 g) was anesthetized with sodium pentobarbital (65 mg/kg, intraperitoneally), and its tail artery was removed quickly and placed in cold Krebs' solution of the following composition (mmol/1): 115.0 NaCl, 5.0 KCl, 25.0 NaHCO3, 1.2 NaH2 PO4, 1.2 MgSO4, 2.1 CaCl2 and 11.0 glucose. Fat and connective tissues surrounding the rat tail arteries were removed carefully and the isolated artery was cannulated at the two ends. The tail arteries were then suspended in organ chambers containing 20 ml of Krebs-Ringer bicarbonate solution containing (mmol/1) 118.3 NaCl, 4.7 KCl, 1.2 MgSO4, 1.2 KH2 PO4, 2.5 CaCl2, 25.0 NaHCO3 and 11.1 glucose (control solution) at 37˚C and bubbled through with 95% O2 and 5% CO2. One of the wires was anchored in the organ chamber and the other was connected to a pressure transducer Statham-Gould type P23ID connected with a polyphysiograph (Narco Bio System, Inc., Houston, TX, USA) Narcotrace 40 and digital recorder Graphtec midi Logger GL820 (Graphtec Corporation, Tokyo, Japan). The rat tail artery was equilibrated at an initial resting tension of 500 mg and the buffer solution was changed every 15 min to stabilize the arterial tissues. The endothelium was removed from specific arteries when necessary. The removal of the endothelium was verified functionally by the lack of relaxant response to acetylcholine (10−5 M) in rat tail arteries precontracted with PHE (10−6 M) (12, 13). The study protocol was approved by the Local Ethics Committee and all experiments were carried out in accordance with the United States NIH guidelines [Guide for the Care and Use of Laboratory Animals (1985), DHEW Publication No. (NIH) 85-23: Office of Science and Health Reports, DRR/NIH, Bethesda, MD, USA]. The study used 15 animals. All animals were purchased from Trójmiejska Akademicka Zwierzętarnia Doświadczalna Centrum Badawczo Usługowe GUMed (Gdańsk, Poland).

Ca2+-free-EGTA solution was prepared by the omission of CaCl2 and the addition of 0.2 mmol/1 EGTA. Prior to data collection, all the rat tails were contracted with PHE (10−6 M) or caffeine (20 mmol/1) in Ca2+-free solution for 5 min to deplete the internal Ca2+ sources.

As the second application of the agonists was significantly diminished, the arterial tissues were subsequently washed with Ca2+-containing Krebs solution three times and incubated for 15 min (Ca2+ loading time). Following this the medium was replaced by Ca2+-free solution and 5 min later PHE (10−6 M) or caffeine (20 mmol/1) was applied to produce a phasic increase of perfusion pressure. Only those tissues exhibiting repeated perfusion pressure responses of a similar magnitude in Ca2+-free solution were selected. In all the experiments, L-NNA, L-arginine, D-arginine, sodium nitroprusside (SNP; 10-7M) and 1H-[1,2,4]oxadiazolo[4,3-α]quinoxalin-1-one (ODQ; 10-5M) were added to the organ chambers at the beginning of the incubation period with Ca2+-free solution. SNP and ODQ were purchased from Sigma Aldrich (Poznan, Poland).

Data analysis

The results are presented as means ± standard error. Statistical analysis was performed using the Newman-Keuls test for multiple comparison of the means, and P<0.05 was considered to indicate a statistically significant difference.

Results

PMI on perfusion pressure

The influence of PMI on perfusion pressure induced by PHE, caffeine, Bay K8644 and KCl was investigated in rat tail arteries in Ca2+-EGTA-PSS, Ca2+-free-EGTA-PSS, with and without endothelium.

PHE (10−6 M) and caffeine (20 mmol/1) evoked a rapid increase of the perfusion pressure of the rat tail arteries in Ca2+-free solution, 137±12 and 73±12 mmHg, respectively (Fig. 1). Perfusion pressure reached its maximal levels within 40 sec and declined thereafter without a sustained perfusion pressure. To exclude the possibility that residual Ca2+ in Ca2+-free solution may play a role in the contractile responses, KCl (40 mmol/1), which can only stimulate Ca2+ entry through the plasma membrane, was applied after incubation with Ca2+-free solution for 5 min, but it could not induce an increase of perfusion pressure. Bay K8644 (10−6 M), which can stimulate only Ca2+ entry through the plasma membrane, was also applied after incubation with Ca2+-free solution for 5 min, but it also could not induce an increase perfusion pressure. Thus, an increase of perfusion pressure induced in Ca2+-free-EGTA-PSS by PHE and caffeine are caused by intracellular Ca2+-release by two different mechanisms, IP3-dependant and -independent, respectively.

Figure 1.

Response of perfused rat tail artery to 1 µΜ phenylephrine (PHE), 20 mmol/1 caffeine, 3 µΜ Bay K8644 and 40 mmol/1 KCl in the Ca2+-ethylene glycol tetraacetic acid (EGTA)-poly(sodium styrenesulfonate) (PSS) and Ca2+-free-EGTA-PSS for control and endothelium-denuded arteries. Data represent means ± standard error of the mean for four experiments.

In Ca2+-EGTA-PSS solution, PHE and caffeine induced a significantly greater increase of perfusion pressure, which reached 183±11 mmHg (n=16) and 93±16 mmHg (n=14) respectively. Furthermore, KCl and Bay K8644 induced an increase of perfusion pressure in Ca2+-EGTA-PSS only. A mean value of maximal perfusion pressure obtained with KCl (40 mmol/1) and Bay K8644 reached 116±15 and 84±10 mmHg, respectively (Fig. 1).

In the Ca2+-free-EGTA-PSS solution after an increase of PMI from 2–8 h, PHE induced elevation of perfusion pressure significantly decreased. After 2 h PMI, an increase of maximal perfusion pressure induced by PHE reached 49±14 mmHg only (n=16). Furthermore, an increase of PMI to 4 and 8 h depleted the response on PHE to 16±9 and 8±7 mmHg, respectively (Fig. 2). PHE also induced an increase of perfusion pressure in Ca2+-EGTA-PSS, which significantly decreased with the increase of PMI. The mean maximal response to PHE reached 183±22 mmHg in the control and after 2, 4 and 8 h PMI depleted to 137±23, 34±12 and 18±9 mmHg, respectively (Fig. 2).

Figure 2.

Influence of post-mortem interval (PMI) (2, 4 and 8 h) on the responses of perfused rat tail arteries to 1 µΜ phenylephrine (PHE) in the Ca2+-EGTA-PSS and Ca2+-free-ethylene glycol tetraacetic acid (EGTA)-poly(sodium styrenesulfonate) (PSS) for control and endothelium-denuded arteries. Data represent means ± standard error for n=16.

By contrast, rat tail artery responses to caffeine (20 mmol/1) in Ca2+-free-EGTA-PSS solution did not change significantly with an increase of PMI from 2–8 h (Fig. 3). The mean maximal responses oscillated from 78±15 mmHg after 2 h PMI to 62±11 mmHg after 8 h PMI (Fig. 3).

Figure 3.

Influence of post-mortem interval (PMI) (2, 4 and 8 h) on the responses of perfused rat tail arteries to 20 mmol/1 caffeine in the Ca2+-ethylene glycol tetraacetic acid (EGTA)-poly(sodium styrenesulfonate) (PSS) and Ca2+-free-EGTA-PSS for control and endothelium-denuded arteries. Data represents means ± standard error for n=12.

Similar effects in Ca2+-EGTA-PSS were observed with KCl (40 mmol/1), which induced an increase in perfusion pressure of the rat tail arteries. In this condition, the mean maximal responses slightly decreased and oscillated between 116±15 mmHg in the control response and 121±17, 119±14 and 98±12 mmHg after 2, 4 and 8 h PMI, respectively (Fig. 4).

Figure 4.

Influence of post-mortem interval (PMI) (2, 4 and 8 h) on the responses of perfused rat tail arteries to 40 mmol/1 KCl, in the Ca2+-ethylene glycol tetraacetic acid (EGTA)-poly(sodium styrenesulfonate) (PSS) and Ca2+-free-EGTA-PSS for control and endothelium-denuded arteries. Data represents means ± standard error for n=14.

Discussion

The estimation of PMI remains an ambiguous problem in forensic investigations (3). The use of calmodulin (CaM) binding proteins (CaMBPs) as indicators of PMI has been investigated previously. In lung tissue samples, Ca2+/CaM-dependent protein kinase II (CaMKII) levels did not significantly change over the 96 h PMI time period examined. The stability of CaMKII levels over 96 h was also observed in skeletal muscle tissue, whereas calcineurin A (CNA) showed variable levels at 0, 48 and 96 h with the presence of the rapidly migrating band at 24 h. Kang et al analyzed specific CaMBPs, Ca(2+)/CaM-dependent kinase II, calcineurin A in immunoblot analysis. These patterns of change in CaMBPs provide insight into the post-mortem changes in CaM-mediated signaling components in lung and skeletal muscle and support the further study of CNA and CaMKII as potential markers for estimating short- and long-term PMIs (3).

By contrast, inducible NOS levels, which vary between samples, CNA and myristoylated alanine-rich C-kinase substrate (MARCKS) exhibited predictable patterns of change; the level of MARCKS decreased steadily in the 0–96 h post-mortem lung samples (14).

In the present study, the possible use of vascular responses to PHE, Bay K, caffeine and KCl were examined as indicators of PMI. All the models were allowed to determine the time of laying within a period of ~2 h and consequently this was determined as the time of death; under favorable conditions the species lays immediately following death.

The majority of systemic vessels relax, but pulmonary vessels contract when exposed to hypoxia; the mechanisms are likely to be diverse. Vascular and cardiac endothelium releases are the last three chemical messengers that may influence vascular and cardiac performance. First, endothelial cells express NOS (constitutive and inducible form). NO release by endothelial cells has been shown to elevate vascular cGMP. Post-mortem, the energy metabolism is disrupted and the endothelial cells lose Ca2+ from the ER and the cytosolic Ca2+ concentration increases. An increase in Ca2+ may also occur under pathophysiological conditions, such as during hypoxia or ischemia, when the endothelial cells start developing an energy deficit. The study by Coburn et al (15) indicated that hypoxic relaxation is not only a function of energy stores, and that oxidative metabolism-contraction coupling is regulated by energy delivery to a reaction, or reactions that are controlling muscle force.

Tosun et al (9) suggested that oxygen sensing mechanisms may modulate the cell signaling pathways involved in excitation-contraction coupling, including mechanisms in which Ca2+ is the regulated parameter, for example by oxygen-dependent or adenosine triphosphate-dependent changes in Ca2+ permeability.

The present study investigated, by means of perfusion pressure in rat tail arteries, the role of the Ca2+ in vascular response to activation of α-1 adrenoceptor by PHE and Bay K8644 (agonist of L-type calcium channel) before and after 2, 4, 6 and 8 h PMI. A phasic increase of perfusion pressure in the rat tail arteries induced by PHE or caffeine in Ca2+-free solution were used as an indicator of intracellular Ca2+ release through the inositol IP3 and ryanodine receptor pathways, respectively. Bay K8644 and KCl induced an increase in perfusion pressure in Ca2+-PSS only, and this increase was used as an indicator of Ca2+-influx from the extracellular space to the cytoplasm through the Ca2+-channel in the cellular membrane. The influence of PMI on the PHE- and caffeine-induced phasic contractions in Ca2+-free solution in the intact endothelium and endothelium denuded rat tail arteries was studied.

To confirm whether the inhibitory effect of 2, 4, 6 and 8 h PMI was mediated through NO formation, L-NNA was used and compared to the effect of the inhibitor, COX indomethacin. Exposure to L-NNA (10−5 M) blocked the inhibition induced by increase PMI. The blocked effects of L-NNA could be reversed by L-arginine (10−4 M). An elevated intracellular concentration of free calcium ions is considered a primary toxic mechanism in tissue damage (2, 16–18). Mobilization tissues and the influx of calcium has long been considered as a major mechanism of ischemic cell death induced by different means, including ischemia (7, 19–21). The increased concentration of cytoplasmic free Ca2+ following hypoxia is derived from an influx and release from intracellular storage, such as ER and mitochondria (6, 8, 22).

Previous evidence indicated that mobilization of the intracellular calcium is in itself sufficient to activate apoptosis (14). This is supported by the finding that NOS inhibition elevated the resistance to treatment with CaCl2, which mimics hypoxic stress and leads to the influx of calcium (4, 6, 22). Treatment with 300 µM CaCl2 is commonly used to mimic hypoxic insults in vivo and in vitro.

In conclusion, these patterns of change in arteries responses provide insight into the post-mortem change in receptor mediated signaling components in epithelial and smooth muscle cells and support the further study of post-mortem vascular responses triggered by G protein coupled receptors (metabotropic) and channel linked receptors (ionotropic) as potential markers for estimating short- and long-term PMIs, respectively.

References

1 

Blatter LA and Wier WG: Nitric oxide decreases [Ca2+]i in vascular smooth muscle by inhibition of the calcium current. Cell Calcium. 15:122–131. 1994. View Article : Google Scholar : PubMed/NCBI

2 

Colton CA, Fagni L and Gilbert D: The action of hydrogen peroxide on paired pulse and long term potentiation in the hippocampus. Free Radic Biol Med. 7:3–8. 1989. View Article : Google Scholar : PubMed/NCBI

3 

Kang S, Kassam N, Gauthier ML and O'Day DH: Post-mortem changes in calmodulin binding proteins in muscle and lung. Forensic Sci Int. 131:140–147. 2003. View Article : Google Scholar : PubMed/NCBI

4 

Koh JY and Choi DW: Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods. 20:83–90. 1987. View Article : Google Scholar : PubMed/NCBI

5 

Grześk G, Wiciński M, Malinowski B, Grześk E, Manysiak S, Odrowąż-Sypniewska G, Darvish N and Birwagen M: Calcium blockers inhibit cyclosporine A-induced hyperreactivity of vascular smooth muscle cells. Mol Med Rep. 5:1469–1474. 2012.PubMed/NCBI

6 

Slupski M, Szadujkis-Szadurski L, Grześk G, Szadujkis-Szadurski R, Szadujkis-Szadurska K, Wlodarczyk Z, Masztalerz M, Piotrowiak I and Jasiński M: Guanylate cyclase activators influence reactivity of human mesenteric superior arteries retrieved and preserved in the same conditions as transplanted kidneys. Transplant Proc. 39:1350–1353. 2007. View Article : Google Scholar : PubMed/NCBI

7 

Depre C, Fierain L and Hue L: Activation of nitric oxide synthase by ischemia in the perfused heart. Cardiovasc Res. 33:82–87. 1997. View Article : Google Scholar : PubMed/NCBI

8 

Ikonomidou C, Mosinger JL, Salles KS, Labruyere J and Olney JW: Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity. J Neurosci. 9:2809–2818. 1989.PubMed/NCBI

9 

Tosun M, Paul RJ and Rapoport RM: Intracellular Ca2+ elevation and contraction due to prostaglandin F2α in rat aorta. Eur J Pharmacol. 340:203–208. 1997. View Article : Google Scholar : PubMed/NCBI

10 

Willmott NJ, Galione A and Smith PA: Nitric oxide induces intracellular Ca2+ mobilization and increases secretion of incorporated 5-hydroxytryptamine in rat pancreatic β-cells. FEBS Lett. 371:99–104. 1995. View Article : Google Scholar : PubMed/NCBI

11 

Bloch-Bogusławska E: The effect of the time of death on the reactivity of rat caudal artery regulated by Bay-K 8644 (an agonist directly affecting the Ca channel). Arch Med Sadowej Kryminol. 56:132–135. 2006.(In Polish). PubMed/NCBI

12 

Grześk G and Szadujkis-Szadurski L: Pharmacometric analysis of α 1-adrenoceptor function in rat tail artery pretreated with lipopolysaccharides. Pol J Pharmacol. 53:605–613. 2001.PubMed/NCBI

13 

Grześk G, Kozinski M, Tantry US, Wicinski M, Fabiszak T, Navarese EP, Grzesk E, Jeong YH, Gurbel PA and Kubica J: High-dose, but not low-dose, aspirin impairs anticontractile effect of ticagrelor following ADP stimulation in rat tail artery smooth muscle cells. Biomed Res Int. 2013:9282712013. View Article : Google Scholar : PubMed/NCBI

14 

Kanner J, Harel S and Granit R: Nitric oxide, an inhibitor of lipid oxidation by lipooxygenase, cyclooxygenase and hemoglobin. Lipids. 27:46–49. 1992. View Article : Google Scholar : PubMed/NCBI

15 

Coburn RF, Moreland S, Moreland RS and Baron CB: Rate-limiting energy-dependent steps controlling oxidative metabolism-contraction coupling in rabbit aorta. J Physiol. 448:473–492. 1992. View Article : Google Scholar : PubMed/NCBI

16 

Aizenman E, Hartnett KA and Reynolds IJ: Oxygen free radicals regulate NMDA receptor function via a redox modulatory site. Neuron. 5:841–846. 1990. View Article : Google Scholar : PubMed/NCBI

17 

Bredt DS, Hwang PM and Snyder SH: Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 347:768–770. 1990. View Article : Google Scholar : PubMed/NCBI

18 

Choi DW: Nitric oxide: foe or friend to the injured brain? Proc Natl Acad Sci USA. 90:9741–9743. 1993. View Article : Google Scholar : PubMed/NCBI

19 

Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR, Wu Z, Huang F, Xia H, Peters MF, et al: Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α 1-synthropin mediated by PDZ domains Cell. 84:757–767. 1996.PubMed/NCBI

20 

Choi DW: Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:623–634. 1988. View Article : Google Scholar : PubMed/NCBI

21 

Furchgott RF and Vanhoutte PM: Endothelium-derived relaxing and contracting factors. FASEB J. 3:2007–2018. 1989.PubMed/NCBI

22 

Szadujkis-Szadurska K, Grzesk G, Szadujkis-Szadurski L, Gajdus M and Matusiak G: Role of nitric oxide and cGMP in the modulation of vascular contraction induced by angiotensin II and Bay K8644 during ischemia/reperfusion. Exp Ther Med. 5:616–620. 2013.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Bloch‑Bogusławska E, Grześk E and Grześk G: Comparison of the post-mortem interval on the effect of vascular responses to the activation of ionotropic and metabotropic receptors. Biomed Rep 3: 230-234, 2015.
APA
Bloch‑Bogusławska, E., Grześk, E., & Grześk, G. (2015). Comparison of the post-mortem interval on the effect of vascular responses to the activation of ionotropic and metabotropic receptors. Biomedical Reports, 3, 230-234. https://doi.org/10.3892/br.2014.396
MLA
Bloch‑Bogusławska, E., Grześk, E., Grześk, G."Comparison of the post-mortem interval on the effect of vascular responses to the activation of ionotropic and metabotropic receptors". Biomedical Reports 3.2 (2015): 230-234.
Chicago
Bloch‑Bogusławska, E., Grześk, E., Grześk, G."Comparison of the post-mortem interval on the effect of vascular responses to the activation of ionotropic and metabotropic receptors". Biomedical Reports 3, no. 2 (2015): 230-234. https://doi.org/10.3892/br.2014.396
Copy and paste a formatted citation
x
Spandidos Publications style
Bloch‑Bogusławska E, Grześk E and Grześk G: Comparison of the post-mortem interval on the effect of vascular responses to the activation of ionotropic and metabotropic receptors. Biomed Rep 3: 230-234, 2015.
APA
Bloch‑Bogusławska, E., Grześk, E., & Grześk, G. (2015). Comparison of the post-mortem interval on the effect of vascular responses to the activation of ionotropic and metabotropic receptors. Biomedical Reports, 3, 230-234. https://doi.org/10.3892/br.2014.396
MLA
Bloch‑Bogusławska, E., Grześk, E., Grześk, G."Comparison of the post-mortem interval on the effect of vascular responses to the activation of ionotropic and metabotropic receptors". Biomedical Reports 3.2 (2015): 230-234.
Chicago
Bloch‑Bogusławska, E., Grześk, E., Grześk, G."Comparison of the post-mortem interval on the effect of vascular responses to the activation of ionotropic and metabotropic receptors". Biomedical Reports 3, no. 2 (2015): 230-234. https://doi.org/10.3892/br.2014.396
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team